KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 134 filers reported holding KARUNA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,110,000 | +83.3% | 18,271 | +3.1% | 0.04% | +77.3% |
| Q2 2022 | $2,242,000 | -42.3% | 17,724 | -42.1% | 0.02% | -47.6% |
| Q1 2022 | $3,884,000 | -13.5% | 30,637 | -10.6% | 0.04% | -17.6% |
| Q4 2021 | $4,491,000 | +1.4% | 34,281 | -5.4% | 0.05% | +18.6% |
| Q3 2021 | $4,431,000 | +0.5% | 36,219 | -6.4% | 0.04% | +10.3% |
| Q2 2021 | $4,411,000 | -30.2% | 38,697 | -26.4% | 0.04% | -37.1% |
| Q1 2021 | $6,323,000 | +29.4% | 52,588 | +9.3% | 0.06% | +12.7% |
| Q4 2020 | $4,887,000 | +86.2% | 48,107 | +41.8% | 0.06% | +41.0% |
| Q3 2020 | $2,624,000 | -34.0% | 33,937 | -4.8% | 0.04% | -26.4% |
| Q2 2020 | $3,973,000 | +16.7% | 35,648 | -24.6% | 0.05% | 0.0% |
| Q1 2020 | $3,405,000 | -13.8% | 47,290 | -9.8% | 0.05% | +71.0% |
| Q4 2019 | $3,948,000 | – | 52,408 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |